ISTODAX
Live / Registered — Registered — Section 71 accepted (as of 09 Apr 2018)
What this means for you
Registered since 31 Mar 2009. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79058882
- Registration number
- 3598805
- Mark type
- Word mark
- Filed
- 22 Aug 2008
- Published for opposition
- 13 Jan 2009
- Registered
- 31 Mar 2009
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations as an anti-cancer drug for human uses
Owner
- Celgene Corporation, Summit, NJ, US
- Astellas Pharma Inc., JP
- Astellas Pharma Inc., JP
- Astellas Pharma Inc., JP
Prosecution history
- 08 Sept 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 May 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Sept 2018 — INTERNATIONAL REGISTRATION RENEWED
- 09 Apr 2018 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 09 Apr 2018 — REGISTERED-SEC.71 ACCEPTED
- 02 Apr 2018 — TEAS SECTION 71 RECEIVED
- 31 Mar 2018 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 10 Sept 2015 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Jul 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Jul 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 May 2014 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 08 May 2014 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 01 Apr 2014 — REGISTERED - SEC. 71 & SEC. 15 FILED
- 07 May 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 01 Apr 2014 — TEAS SECTION 71 & 15 RECEIVED